Effect of Acute Hyperglycemia on Left Ventricular Contractile Function in Diabetic Patients with and without Heart Failure: Two Randomized Cross-Over Studies

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Nielsen, Roni ^a   Nørrelund, Helene ^b   Kampmann, Ulla ^a   Bøtker, Hans Erik ^a   Møller, Niels ^a   Wiggers, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOSE; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; BLOOD FLOW VELOCITY; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERGLYCEMIA; MALE; MITRAL VALVE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRESS STRAIN RELATIONSHIP; SYSTOLIC HEART FAILURE; WALKING;

AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, SYSTOLIC; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; VENTRICULAR FUNCTION, LEFT; WALKING;

EID: 84872186243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053247     Document Type: Article

References (41)

1. Murarka S, Movahed MR, (2010) Diabetic Cardiomyopathy. Journal of Cardiac Failure 16: 971-979.
2. Norrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, et al. (2006) Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med 260: 11-21.
3. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, et al. (1997) Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30: 527-532.
4. Young ME, McNulty P, Taegtmeyer H, (2002) Adaptation and Maladaptation of the Heart in Diabetes: Part II. Circulation 105: 1861-1870.
5. Sondergaard HM, Bottcher M, Marie Madsen M, Schmitz O, Hansen SB, et al. (2006) Impact of Type 2 Diabetes on Myocardial Insulin Sensitivity to Glucose Uptake and Perfusion in Patients with Coronary Artery Disease. J Clin Endocrinol Metab 91: 4854-4861.
6. Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, et al. (2010) Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. European Heart Journal 31: 100-111.
7. Opie LH, (2004) The metabolic vicious cycle in heart failure. Lancet 364: 1733-1734.
8. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ, (2009) Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovascular Research 81: 420-428.
9. ACCORD study group (2008) Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine 358: 2545-2559.
10. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412.
11. Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, et al. (2010) Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. American Journal of Physiology- Heart and Circulatory Physiology 299: H1220-H1225.
12. Khoury VK, Haluska B, Prins J, Marwick TH, (2003) Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart 89: 61-65.
13. Tuunanen H, Engblom E, Naum A, Nagren K, Hesse B, et al. (2006) Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure. Circulation 114: 2130-2137.
14. Wiggers H, Norrelund H, Nielsen SS, Andersen NH, Nielsen-Kudsk JE, et al. (2005) Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol 289: H938-H946.
15. Nielsen TS, Kampmann U, Nielsen RR, Jessen N, Ørskov L, et al. (2012) Reduced mRNA and Protein Expression of Perilipin A and G0/G1 Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism 97: E1348-E1352.
16. Rassam AG, Mcleod J, Burge MR, Schade DS, (1998) Use of the HemoCue Blood Glucose Analyzer in Research Studies. Diabetes Care 21: 1369-1370.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
18. Nikitin NP, Loh PH, Silva R, Ghosh J, Khaleva OY, et al. (2006) Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart 92: 775-779.
19. Ha JW, Ahn JA, Kim JM, Choi EY, Kang SM, et al. (2006) Abnormal Longitudinal Myocardial Functional Reserve Assessed by Exercise Tissue Doppler Echocardiography in Patients with Hypertrophic Cardiomyopathy. Journal of the American Society of Echocardiography 19: 1314-1319.
20. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JGF, (2005) Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. European Heart Journal 26: 778-793.
21. Nikitin NP, Witte KK, Thackray SD, de SR, Clark AL, et al. (2003) Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr 16: 906-921.
22. Tsujita-Kuroda Y, Zhang G, Sumita Y, Hirooka K, Hanatani A, et al. (2000) Validity and Reproducibility of Echocardiographic Measurement of Left Ventricular Ejection Fraction by Acoustic Quantification with Tissue Harmonic Imaging Technique. Journal of the American Society of Echocardiography 13: 300-305.
23. Van Beaumont W, Greenleaf JE, Juhos L, (1972) Disproportional changes in hematocrit, plasma volume, and proteins during exercise and bed rest. Journal of Applied Physiology 33: 55-61.
24. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234.
25. Parsonage WA, Hetmanski D, Cowley AJ, (2001) Beneficial haemodynamic effects of insulin in chronic heart failure. Heart 85: 508-513.
26. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, et al. (2012) Targeting myocardial substrate metabolism in heart failure: potential for new therapies. European Journal of Heart Failure 14: 120-129.
27. Monti LD, Lucignani G, Landoni C, Moresco RM, Piatti P, et al. (1995) Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels. Diabetes 44: 537-542.
28. Hue L, Taegtmeyer H, (2009) The Randle cycle revisited: a new head for an old hat. American Journal of Physiology- Endocrinology And Metabolism 297: E578-E591.
29. Botker HE, Bottcher M, Schmitz O, Gee A, Hansen SB, et al. (1997) Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose. J Nucl Cardiol 4: 125-132.
30. Smogorzewski M, Galfayan V, Massry SG, (1998) High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes. Kidney Int 53: 1237-1243.
31. Frati AC, Rivera C, Espinoza M, Ariza CR, Diaz ME, (1987) Influence of acute hyperglycemia on left ventricular function in diabetics assessed by echocardiography. Clin Cardiol 10: 594-597.
32. Gosselink R, Troosters T, Decramer M, (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. American Journal of Respiratory and Critical Care Medicine 153: 976-980.
33. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Schnohr P, et al. (2009) Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study. European Heart Journal 30: 731-739.
34. Taegtmeyer H, (2000) Metabolism-the lost child of cardiology. Journal of the American College of Cardiology 36: 1386-1388.
35. Wu W, Sun Z, Li Q, Wang M, Miao J, et al. (2012) Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease. Journal of Diabetes and its Complications 26: 83-88.
36. ADVANCE study group (2008) Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine 358: 2560-2572.
37. Fugmann A, Millgard J, Sarabi M, Berne C, Lind L, (2003) Central and peripheral haemodynamic effects of hyperglycaemia, hyperinsulinaemia, hyperlipidaemia or a mixed meal. Clin Sci (Lond) 105: 715-721.
38. Quintard H, Muller L, Philip I, Lena P, Ichai C, (2012) Influence of acute preload changes on mitral annulus velocity measured by tissue doppler echocardiography in critically ill patients. J Clin Ultrasound.
39. Cittadini A, Napoli R, Monti MG, Rea D, Longobardi S, et al. (2012) Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model. Diabetes 61: 944-953.
40. Johansson BL, Sundell J, Ekberg K, Jonsson C, Seppänen M, et al. (2004) C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. American Journal of Physiology- Endocrinology And Metabolism 286: E14-E19.
41. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, et al. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proceedings of the National Academy of Sciences 96: 13318-13323.